ArticleThe FEBS journal2026
Resistance-exercise-induced stress intervenes in TGF-β signaling by cooperatively downregulating nuclear αB-crystallin and SMAD4 in human skeletal muscle fibers.
Article in The FEBS journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Alpha-crystallin B chain (αB-crystallin; CRYAB) helps to maintain proteostasis following cellular stress. Additionally, recent studies in fibroblasts have shown its function in the transforming growth factor beta (TGF-β) pathway, where it stabilizes mothers against decapentaplegic homolog 4 (SMAD4) in the nucleus, enabling target gene transcription. Specifically in skeletal muscle fibers (SkMFs), TGF-β/SMAD4 signaling via myostatin regulates fiber size by inducing growth inhibitors and suppressing the serine/threonine-protein kinase (mTOR) pathway. Conversely, resistance exercise (RE) promotes muscle growth and should therefore affect CRYAB/SMAD4 interaction. However, in human SkMFs, CRYAB's nuclear localization and role in TGF-β/SMAD4 signaling, at rest or after RE, remain undescribed. Therefore, we first validated CRYAB's nuclear localization by small interfering RNA (siRNA)-mediated CRYAB silencing in C2C12 cells (mouse skeletal muscle myoblast cell line) and in human SkMFs via subcellular fractionation and confocal microscopy. To determine the effect of RE on this pathway, skeletal muscle biopsies were taken at rest and 60 min post-RE and analyzed for nuclear localization and phosphorylation of CRYAB and SMAD4, CRYAB/SMAD4 colocalization, and anabolic signaling. CRYAB was localized to C2C12 myoblast nuclei during proliferation but disappeared early during differentiation and was absent in nuclei of myotubes. In contrast, CRYAB was present in nuclei of resting human SkMFs. However, acute RE reduced total CRYAB in SkMF nuclei and increased its phosphorylation at serine 59, which likely promotes its export. Acute RE also reduced both nuclear and cytoplasmic SMAD4 while enhancing anabolic signaling by mTOR and small ribosomal subunit protein eS6 (rpS6) phosphorylation. We conclude that CRYAB and SMAD4 interact in nuclei of human SkMFs and have a coordinated regulation in response to RE-induced mechanical stress, revealing a new perspective on a yet-undescribed mechanism contributing to skeletal muscle adaptation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.